Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer
Antioxidants · 14.12.2023 · 12 (12) · 2112
DOI: 10.3390/antiox12122112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 14.12.2023. Verfasst von María González-Rodríguez und 12 weiteren Autor:innen. Beteiligte Einrichtung: SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology…. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Mediterranean diet is linked to various health benefits, especially the consumption of olive oil as a key component. Multiple studies highlight its advantages, particularly due to its fatty acid composition and additional components like phenolic compounds. A significant antioxidant compound, oleocanthal, known for its antioxidant properties, has gained attention in the pharmaceutical industry for its anti-inflammatory and antiproliferative effects. It shows promise in addressing cardiovascular diseases, metabolic syndrome, and neuroprotection. This systematic review aims to evaluate the existing literature on oleocanthal, examining its role in biological processes and potential impact on conditions like inflammation and cancer.
Methods
We performed several searches in PubMed (MEDLINE), Web of Science (WOS), and Cochrane based on the terms “Oleocanthal”, “Cancer”, and “Inflammation”. The inclusion criteria were as follows: studies whose main topics were oleocanthal and cancer or inflammation. On the other hand, the exclusion criteria were studies that were not focused on oleocanthal, reviews, or editorial material. Given that these findings are explanatory rather than derived from clinical trials, we refrained from employing methods to assess potential bias. This systematic review did not receive any external funding.
Results
We found 174 records from these searches, where we discarded reviews and editorial material, duplicated articles, and 1 retracted article. Finally, we had 53 reports assessed for eligibility that were included in this review.
Discussion
OC exhibits promising therapeutic potential against both inflammation and cancer. We addressed its ability to target inflammatory genes and pathways, offering potential treatments for conditions like rheumatic diseases by regulating pathways such as NF-kB and MAPK. Additionally, OC’s anticancer properties, particularly its notable inhibition of c-Met signaling across various cancers, highlight its efficacy, showcasing promise as a potential treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiago Universit…
- International PhD School of the University of Santiago de Compostela (EDIUS), Doctoral Program in Drug Research and Development, 15782 Santiago de Compostela, Spain.
- National Health Service, Local Health Authority ASL 3 Napoli Sud, Department of Pharmacy, 80056 Naples, Italy.
- Division of Abdominal Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, Ercolano, 80131 Naples, Italy.
- Molecular and Cellular Cardiology Group, SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), Research Laboratory 7, Santiago University Clinical Hospital, 15706 Santiago de Comp…
ORCID-Profile: María González-Rodríguez, Djedjiga Ait Edjoudi, Alfonso Cordero-Barreal, Clara Ruiz-Fernández, Maurizio Capuozzo, Alessandro Ottaiano, Yousof Farrag, Oreste Gualillo
Zitieren
APA
González-Rodríguez, M., Ait Edjoudi, D., Cordero-Barreal, A., Farrag, M., Varela-García, M., Torrijos-Pulpón, C., Ruiz-Fernández, C., Capuozzo, M., Ottaiano, A., Lago, F., Pino, J., Farrag, Y., & Gualillo, O. (2023). Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer. Antioxidants, 12(12), 2112. https://doi.org/10.3390/antiox12122112
Vancouver
González-Rodríguez M, Ait Edjoudi D, Cordero-Barreal A, Farrag M, Varela-García M, Torrijos-Pulpón C, et al. Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer. Antioxidants. 2023;12(12):2112. doi:10.3390/antiox12122112
BibTeX
@article{GonzlezRodrguez2023,
author = {González-Rodríguez, María and Ait Edjoudi, Djedjiga and Cordero-Barreal, Alfonso and Farrag, Mariam and Varela-García, María and Torrijos-Pulpón, Carlos and Ruiz-Fernández, Clara and Capuozzo, Maurizio and Ottaiano, Alessandro and Lago, Francisca and Pino, Jesús and Farrag, Yousof and Gualillo, Oreste},
title = {Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {12},
pages = {2112},
doi = {10.3390/antiox12122112}
}
EUVIMED